{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:03:34Z","timestamp":1793394214257,"version":"4.5.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA206978"],"award-info":[{"award-number":["CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA206978"],"award-info":[{"award-number":["CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA206978"],"award-info":[{"award-number":["CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA206978"],"award-info":[{"award-number":["CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA206978"],"award-info":[{"award-number":["CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA206978"],"award-info":[{"award-number":["CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA206978"],"award-info":[{"award-number":["CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA206978"],"award-info":[{"award-number":["CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA206978"],"award-info":[{"award-number":["CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA206978"],"award-info":[{"award-number":["CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R50CA251956"],"award-info":[{"award-number":["R50CA251956"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA206978"],"award-info":[{"award-number":["CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA213442"],"award-info":[{"award-number":["CA213442"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA206978"],"award-info":[{"award-number":["CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA206978"],"award-info":[{"award-number":["CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA206978"],"award-info":[{"award-number":["CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA206978"],"award-info":[{"award-number":["CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["ALTF 14-2018"],"award-info":[{"award-number":["ALTF 14-2018"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL116324"],"award-info":[{"award-number":["T32HL116324"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["Intramural Research Program"],"award-info":[{"award-number":["Intramural Research Program"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["Intramural Research Program"],"award-info":[{"award-number":["Intramural Research Program"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["BCLLATLAS\/810287"],"award-info":[{"award-number":["BCLLATLAS\/810287"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["BCLLATLAS\/810287"],"award-info":[{"award-number":["BCLLATLAS\/810287"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["BCLLATLAS\/810287"],"award-info":[{"award-number":["BCLLATLAS\/810287"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["BCLLATLAS\/810287"],"award-info":[{"award-number":["BCLLATLAS\/810287"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1074"],"award-info":[{"award-number":["SFB1074"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1074"],"award-info":[{"award-number":["SFB1074"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1074"],"award-info":[{"award-number":["SFB1074"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2017-87811-R"],"award-info":[{"award-number":["SAF2017-87811-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Education of the Basque Government"},{"DOI":"10.13039\/100004316","name":"International Business Machines Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"UT | University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["Moon Shot Program in CLL"],"award-info":[{"award-number":["Moon Shot Program in CLL"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"UT | University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005601","name":"CLL Global Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1038\/s41588-022-01140-w","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T16:02:56Z","timestamp":1659628976000},"page":"1664-1674","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":164,"title":["Molecular map of chronic lymphocytic leukemia and its impact on outcome"],"prefix":"10.1038","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4962-9956","authenticated-orcid":false,"given":"Binyamin A.","family":"Knisbacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8495-6995","authenticated-orcid":false,"given":"Ziao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia K.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2910-9440","authenticated-orcid":false,"given":"Ferran","family":"Nadeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1666-5819","authenticated-orcid":false,"given":"Mart\u00ed","family":"Duran-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen E.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Tausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Barbera-Mourelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaro","family":"Taylor-Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2969-008X","authenticated-orcid":false,"given":"Pablo","family":"Bousquets-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6808-4800","authenticated-orcid":false,"given":"Ander","family":"Diaz-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Dunford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankara","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Kretzmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Gutierrez-Abril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"L\u00f3pez-Tamargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey M.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8498-4729","authenticated-orcid":false,"given":"Clare","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0091-0648","authenticated-orcid":false,"given":"Mariela","family":"Sivina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Z.","family":"Rassenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmi","family":"Parida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8646-7469","authenticated-orcid":false,"given":"Alexander","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9414-300X","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Aguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6177-7572","authenticated-orcid":false,"given":"Jan A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Wiestner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Kipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2040-4961","authenticated-orcid":false,"given":"Jennifer R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hallek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chip","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2566-3145","authenticated-orcid":false,"given":"Donna S.","family":"Neuberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-5195","authenticated-orcid":false,"given":"Jos\u00e9 I.","family":"Mart\u00edn-Subero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9525-1483","authenticated-orcid":false,"given":"Xose S.","family":"Puente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Stilgenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3348-5054","authenticated-orcid":false,"given":"Catherine J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-9793","authenticated-orcid":false,"given":"Elias","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-0753","authenticated-orcid":false,"given":"Gad","family":"Getz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"key":"1140_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature15395","volume":"526","author":"DA Landau","year":"2015","unstructured":"Landau, D. A. et al. Mutations driving CLL and their evolution in progression and relapse. Nature 526, 525 (2015).","journal-title":"Nature"},{"key":"1140_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature14666","volume":"526","author":"XS Puente","year":"2015","unstructured":"Puente, X. S. et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 526, 519 (2015).","journal-title":"Nature"},{"key":"1140_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-019-1252-x","volume":"570","author":"M Gruber","year":"2019","unstructured":"Gruber, M. et al. Growth dynamics in naturally progressing chronic lymphocytic leukaemia. Nature 570, 474\u2013479 (2019).","journal-title":"Nature"},{"key":"1140_CR4","doi-asserted-by":"publisher","first-page":"16802","DOI":"10.1073\/pnas.1413374111","volume":"111","author":"H Dvinge","year":"2014","unstructured":"Dvinge, H. et al. Sample processing obscures cancer-specific alterations in leukemic transcriptomes. Proc. Natl Acad. Sci. USA 111, 16802\u201316807 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1140_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1101\/gr.152132.112","volume":"24","author":"PG Ferreira","year":"2014","unstructured":"Ferreira, P. G. et al. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Res. 24, 212\u2013226 (2014).","journal-title":"Genome Res."},{"key":"1140_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ng.3488","volume":"48","author":"CC Oakes","year":"2016","unstructured":"Oakes, C. C. et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nat. Genet. 48, 253\u2013264 (2016).","journal-title":"Nat. Genet."},{"key":"1140_CR7","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.2443","volume":"44","author":"M Kulis","year":"2012","unstructured":"Kulis, M. et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat. Genet. 44, 1236\u20131242 (2012).","journal-title":"Nat. Genet."},{"key":"1140_CR8","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41591-018-0028-4","volume":"24","author":"R Beekman","year":"2018","unstructured":"Beekman, R. et al. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia. Nat. Med. 24, 868\u2013880 (2018).","journal-title":"Nat. Med."},{"key":"1140_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25403-y","volume":"12","author":"J Bloehdorn","year":"2021","unstructured":"Bloehdorn, J. et al. Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia. Nat. Commun. 12, 5395 (2021).","journal-title":"Nat. Commun."},{"key":"1140_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02329-y","volume":"8","author":"DA Landau","year":"2017","unstructured":"Landau, D. A. et al. The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy. Nat. Commun. 8, 2185 (2017).","journal-title":"Nat. Commun."},{"key":"1140_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9866","volume":"6","author":"S Kasar","year":"2015","unstructured":"Kasar, S. et al. Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution. Nat. Commun. 6, 8866 (2015).","journal-title":"Nat. Commun."},{"key":"1140_CR12","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S1470-2045(14)70335-3","volume":"15","author":"JA Burger","year":"2014","unstructured":"Burger, J. A. et al. Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study. Lancet Oncol. 15, 1090\u20131099 (2014).","journal-title":"Lancet Oncol."},{"key":"1140_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11589","volume":"7","author":"JA Burger","year":"2016","unstructured":"Burger, J. A. et al. Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition. Nat. Commun. 7, 11589 (2016).","journal-title":"Nat. Commun."},{"key":"1140_CR14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41586-019-1651-z","volume":"574","author":"S Shuai","year":"2019","unstructured":"Shuai, S. et al. The U1 spliceosomal RNA is recurrently mutated in multiple cancers. Nature 574, 712\u2013716 (2019).","journal-title":"Nature"},{"key":"1140_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15746","volume":"8","author":"C Minici","year":"2017","unstructured":"Minici, C. et al. Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia. Nat. Commun. 8, 15746 (2017).","journal-title":"Nat. Commun."},{"key":"1140_CR16","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1073\/pnas.1913810117","volume":"117","author":"PC Maity","year":"2020","unstructured":"Maity, P. C. et al. IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling. Proc. Natl Acad. Sci. USA 117, 4320\u20134327 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1140_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","volume":"505","author":"MS Lawrence","year":"2014","unstructured":"Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495 (2014).","journal-title":"Nature"},{"key":"1140_CR18","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/ajh.25831","volume":"95","author":"G Kleinstern","year":"2020","unstructured":"Kleinstern, G. et al. Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B\u2010cell lymphocytosis beyond the CLL international prognostic index. Am. J. Hematol. 95, 906\u2013917 (2020).","journal-title":"Am. J. Hematol."},{"key":"1140_CR19","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41375-018-0215-9","volume":"33","author":"AC Leeksma","year":"2019","unstructured":"Leeksma, A. C. et al. Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia. Leukemia 33, 390\u2013402 (2019).","journal-title":"Leukemia"},{"key":"1140_CR20","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","volume":"152","author":"DA Landau","year":"2013","unstructured":"Landau, D. A. et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152, 714\u2013726 (2013).","journal-title":"Cell"},{"key":"1140_CR21","doi-asserted-by":"publisher","first-page":"E5486","DOI":"10.1073\/pnas.1516373112","volume":"112","author":"A Kamburov","year":"2015","unstructured":"Kamburov, A. et al. Comprehensive assessment of cancer missense mutation clustering in protein structures. Proc. Natl Acad. Sci. USA 112, E5486\u2013E5495 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1140_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nsmb1184","volume":"14","author":"A Dziembowski","year":"2007","unstructured":"Dziembowski, A., Lorentzen, E., Conti, E. & S\u00e9raphin, B. A single subunit, Dis3, is essentially responsible for yeast exosome core activity. Nat. Struct. Mol. Biol. 14, 15\u201322 (2007).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1140_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature09837","volume":"471","author":"MA Chapman","year":"2011","unstructured":"Chapman, M. A. et al. Initial genome sequencing and analysis of multiple myeloma. Nature 471, 467\u2013472 (2011).","journal-title":"Nature"},{"key":"1140_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nbt.3391","volume":"34","author":"MT Chang","year":"2016","unstructured":"Chang, M. T. et al. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat. Biotechnol. 34, 155\u2013163 (2016).","journal-title":"Nat. Biotechnol."},{"key":"1140_CR25","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jmb.2006.05.043","volume":"360","author":"M Amblar","year":"2006","unstructured":"Amblar, M., Barbas, A., Fialho, A. M. & Arraiano, C. M. Characterization of the functional domains of Escherichia coli RNase II. J. Mol. Biol. 360, 921\u2013933 (2006).","journal-title":"J. Mol. Biol."},{"key":"1140_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2010.12.021","volume":"144","author":"M Papamichos-Chronakis","year":"2011","unstructured":"Papamichos-Chronakis, M., Watanabe, S., Rando, O. J. & Peterson, C. L. Global regulation of H2A.Z localization by the INO80 chromatin-remodeling enzyme is essential for genome integrity. Cell 144, 200\u2013213 (2011).","journal-title":"Cell"},{"key":"1140_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","volume":"7","author":"M McKinney","year":"2017","unstructured":"McKinney, M. et al. The genetic basis of hepatosplenic T-cell lymphoma. Cancer Discov. 7, 369\u2013379 (2017).","journal-title":"Cancer Discov."},{"key":"1140_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08578-3","volume":"10","author":"C L\u00f3pez","year":"2019","unstructured":"L\u00f3pez, C. et al. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma. Nat. Commun. 10, 1459 (2019).","journal-title":"Nat. Commun."},{"key":"1140_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09180-3","volume":"10","author":"J Weber","year":"2019","unstructured":"Weber, J. et al. PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice. Nat. Commun. 10, 1415 (2019).","journal-title":"Nat. Commun."},{"key":"1140_CR30","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.1182\/blood-2012-04-423517","volume":"120","author":"J Edelmann","year":"2012","unstructured":"Edelmann, J. et al. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 120, 4783\u20134794 (2012).","journal-title":"Blood"},{"key":"1140_CR31","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1365-2141.2010.08341.x","volume":"151","author":"SR Setlur","year":"2010","unstructured":"Setlur, S. R. et al. Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization. Br. J. Haematol. 151, 336\u2013345 (2010).","journal-title":"Br. J. Haematol."},{"key":"1140_CR32","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/sj.leu.2401499","volume":"13","author":"S Stilgenbauer","year":"1999","unstructured":"Stilgenbauer, S. et al. Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia. Leukemia 13, 1331\u20131334 (1999).","journal-title":"Leukemia"},{"key":"1140_CR33","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1182\/blood.V99.12.4638","volume":"99","author":"J Boultwood","year":"2002","unstructured":"Boultwood, J. et al. Narrowing and genomic annotation of the commonly deleted region of the 5q\u2212 syndrome. Blood 99, 4638\u20134641 (2002).","journal-title":"Blood"},{"key":"1140_CR34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nm.4047","volume":"22","author":"RK Schneider","year":"2016","unstructured":"Schneider, R. K. et al. Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9. Nat. Med. 22, 288\u2013297 (2016).","journal-title":"Nat. Med."},{"key":"1140_CR35","doi-asserted-by":"publisher","first-page":"18631","DOI":"10.1073\/pnas.1422488112","volume":"111","author":"A Ciccia","year":"2014","unstructured":"Ciccia, A. et al. Treacher Collins syndrome TCOF1 protein cooperates with NBS1 in the DNA damage response. Proc. Natl Acad. Sci. 111, 18631\u201318636 (2014).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1140_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9137","volume":"6","author":"SM Nowinski","year":"2015","unstructured":"Nowinski, S. M. et al. Mitochondrial uncoupling links lipid catabolism to Akt inhibition and resistance to tumorigenesis. Nat. Commun. 6, 8137 (2015).","journal-title":"Nat. Commun."},{"key":"1140_CR37","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1016\/j.celrep.2019.07.097","volume":"28","author":"E Aguilar","year":"2019","unstructured":"Aguilar, E. et al. UCP2 Deficiency increases colon tumorigenesis by promoting lipid synthesis and depleting NADPH for antioxidant defenses. Cell Rep. 28, 2306\u20132316.e5 (2019).","journal-title":"Cell Rep."},{"key":"1140_CR38","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","volume":"18","author":"Z Sondka","year":"2018","unstructured":"Sondka, Z. et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. Nat. Rev. Cancer 18, 696\u2013705 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"1140_CR39","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/leu.2017.177","volume":"32","author":"A Burns","year":"2018","unstructured":"Burns, A. et al. Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups. Leukemia 32, 332\u2013342 (2018).","journal-title":"Leukemia"},{"key":"1140_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","volume":"168","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q., Lenardo, M. J. & Baltimore, D. 30 Years of NF-\u03baB: a blossoming of relevance to human pathobiology. Cell 168, 37\u201357 (2017).","journal-title":"Cell"},{"key":"1140_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2165\/00003088-200241020-00002","volume":"41","author":"V Gandhi","year":"2002","unstructured":"Gandhi, V. & Plunkett, W. Cellular and clinical pharmacology of fludarabine. Clin. Pharmacokinet. 41, 93\u2013103 (2002).","journal-title":"Clin. Pharmacokinet."},{"key":"1140_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2141.2007.06636.x","volume":"138","author":"L Sellmann","year":"2007","unstructured":"Sellmann, L. et al. Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B\u2010chronic lymphocytic leukaemia. Br. J. Haematol. 138, 217\u2013220 (2007).","journal-title":"Br. J. Haematol."},{"key":"1140_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev-biochem-051710-134100","volume":"81","author":"A Shilatifard","year":"2012","unstructured":"Shilatifard, A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu. Rev. Biochem. 81, 65\u201395 (2012).","journal-title":"Annu. Rev. Biochem."},{"key":"1140_CR44","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/ajh.25831","volume":"95","author":"G Kleinstern","year":"2020","unstructured":"Kleinstern, G. et al. Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index. Am. J. Hematol. 95, 906\u2013917 (2020).","journal-title":"Am. J. Hematol."},{"key":"1140_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17095-7","volume":"11","author":"F Nadeu","year":"2020","unstructured":"Nadeu, F. et al. IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms. Nat. Commun. 11, 3390 (2020).","journal-title":"Nat. Commun."},{"key":"1140_CR46","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/ni.1901","volume":"11","author":"DJ Hodson","year":"2010","unstructured":"Hodson, D. J. et al. Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia. Nat. Immunol. 11, 717\u2013724 (2010).","journal-title":"Nat. Immunol."},{"key":"1140_CR47","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1182\/blood-2002-10-3175","volume":"101","author":"P Oppezzo","year":"2003","unstructured":"Oppezzo, P. et al. Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. Blood 101, 4029\u20134032 (2003).","journal-title":"Blood"},{"key":"1140_CR48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.immuni.2019.07.001","volume":"51","author":"JA Roco","year":"2019","unstructured":"Roco, J. A. et al. Class-switch recombination occurs infrequently in germinal centers. Immunity 51, 337\u2013350.e7 (2019).","journal-title":"Immunity"},{"key":"1140_CR49","doi-asserted-by":"publisher","unstructured":"Leshchiner, I. et al. Comprehensive analysis of tumour initiation, spatial and temporal progression under multiple lines of treatment. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/508127 (2019).","DOI":"10.1101\/508127"},{"key":"1140_CR50","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1182\/blood.2019004492","volume":"135","author":"E Tausch","year":"2020","unstructured":"Tausch, E. et al. Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax. Blood 135, 2402\u20132412 (2020).","journal-title":"Blood"},{"key":"1140_CR51","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41375-019-0602-x","volume":"34","author":"JA Burger","year":"2020","unstructured":"Burger, J. A. et al. Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL\/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study. Leukemia 34, 787\u2013798 (2020).","journal-title":"Leukemia"},{"key":"1140_CR52","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/s43018-020-00131-2","volume":"1","author":"M Duran-Ferrer","year":"2020","unstructured":"Duran-Ferrer, M. et al. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome. Nat. Cancer 1, 1066\u20131081 (2020).","journal-title":"Nat. Cancer"},{"key":"1140_CR53","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2141.2007.06636.x","volume":"138","author":"L Sellmann","year":"2007","unstructured":"Sellmann, L. et al. Trisomy 19 is associated with trisomy 12 and mutatedIGHVgenes in B-chronic lymphocytic leukaemia. Br. J. Haematol. 138, 217\u2013220 (2007).","journal-title":"Br. J. Haematol."},{"key":"1140_CR54","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1182\/blood.2020008311","volume":"137","author":"F Nadeu","year":"2021","unstructured":"Nadeu, F. et al. IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics.Blood 137, 2395\u20132946 (2021).","journal-title":"Blood"},{"key":"1140_CR55","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1182\/blood.2020007039","volume":"137","author":"A Agathangelidis","year":"2021","unstructured":"Agathangelidis, A. et al. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. Blood 137, 1365\u20131376 (2021).","journal-title":"Blood"},{"key":"1140_CR56","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.bbrc.2005.03.155","volume":"331","author":"M Dobbelstein","year":"2005","unstructured":"Dobbelstein, M., Strano, S., Roth, J. & Blandino, G. p73-induced apoptosis: a question of compartments and cooperation. Biochem. Biophys. Res. Commun. 331, 688\u2013693 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1140_CR57","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1038\/onc.2009.40","volume":"27","author":"G Chinnadurai","year":"2008","unstructured":"Chinnadurai, G., Vijayalingam, S. & Rashmi, R. BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene 27, S20\u2013S29 (2008).","journal-title":"Oncogene"},{"key":"1140_CR58","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1172\/JCI97712","volume":"129","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT\/mTOR signaling. J. Clin. Invest. 129, 1015\u20131029 (2019).","journal-title":"J. Clin. Invest."},{"key":"1140_CR59","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/S1470-2045(19)30503-0","volume":"20","author":"CD Herling","year":"2019","unstructured":"Herling, C. D. et al. Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study. Lancet Oncol. 20, 1576\u20131586 (2019).","journal-title":"Lancet Oncol."},{"key":"1140_CR60","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/sj.leu.2404220","volume":"20","author":"M Bilban","year":"2006","unstructured":"Bilban, M. et al. Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia 20, 1080\u20131088 (2006).","journal-title":"Leukemia"},{"key":"1140_CR61","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1172\/JCI93801","volume":"128","author":"S Dietrich","year":"2018","unstructured":"Dietrich, S. et al. Drug-perturbation-based stratification of blood cancer. J. Clin. Invest. 128, 427\u2013445 (2018).","journal-title":"J. Clin. Invest."},{"key":"1140_CR62","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1182\/blood-2014-01-546150","volume":"123","author":"S Stilgenbauer","year":"2014","unstructured":"Stilgenbauer, S. et al. Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial. Blood 123, 3247\u20133254 (2014).","journal-title":"Blood"},{"key":"1140_CR63","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1182\/blood.V124.21.1991.1991","volume":"124","author":"S Stilgenbauer","year":"2014","unstructured":"Stilgenbauer, S. et al. Alemtuzumab combined with dexamethasone, followed by alemtuzumab maintenance or Allo-SCT in \u2018ultra high-risk\u2019 CLL: Final results from the CLL2O phase II study. Blood 124, 1991\u20131991 (2014).","journal-title":"Blood"},{"key":"1140_CR64","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","volume":"365","author":"L Wang","year":"2011","unstructured":"Wang, L. et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N. Engl. J. Med. 365, 2497\u20132506 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1140_CR65","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.ccell.2014.10.012","volume":"26","author":"DA Landau","year":"2014","unstructured":"Landau, D. A. et al. Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia. Cancer Cell 26, 813\u2013825 (2014).","journal-title":"Cancer Cell"},{"key":"1140_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17453-5","volume":"11","author":"N Javed","year":"2020","unstructured":"Javed, N. et al. Detecting sample swaps in diverse NGS data types using linkage disequilibrium. Nat. Commun. 11, 3697 (2020).","journal-title":"Nat. Commun."},{"key":"1140_CR67","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"1140_CR68","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/nar\/gks1443","volume":"41","author":"M Costello","year":"2013","unstructured":"Costello, M. et al. Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation. Nucleic Acids Res. 41, e67 (2013).","journal-title":"Nucleic Acids Res."},{"key":"1140_CR69","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1093\/bioinformatics\/btr446","volume":"27","author":"K Cibulskis","year":"2011","unstructured":"Cibulskis, K. et al. ContEst: estimating cross-contamination of human samples in next-generation sequencing data. Bioinformatics 27, 2601\u20132602 (2011).","journal-title":"Bioinformatics"},{"key":"1140_CR70","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature09744","volume":"470","author":"MF Berger","year":"2011","unstructured":"Berger, M. F. et al. The genomic complexity of primary human prostate cancer. Nature 470, 214\u2013220 (2011).","journal-title":"Nature"},{"key":"1140_CR71","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat. Biotechnol."},{"key":"1140_CR72","doi-asserted-by":"publisher","unstructured":"Benjamin, D. et al. Calling somatic SNVs and indels with Mutect2. Preprint at bioRxiv 861054 https:\/\/doi.org\/10.1101\/861054 (2019).","DOI":"10.1101\/861054"},{"key":"1140_CR73","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat. Methods 15, 591\u2013594 (2018).","journal-title":"Nat. Methods"},{"key":"1140_CR74","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41592-018-0036-9","volume":"15","author":"A Taylor-Weiner","year":"2018","unstructured":"Taylor-Weiner, A. et al. DeTiN: overcoming tumor-in-normal contamination. Nat. Methods 15, 531\u2013534 (2018).","journal-title":"Nat. Methods"},{"key":"1140_CR75","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"1140_CR76","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/ng.3557","volume":"48","author":"J Kim","year":"2016","unstructured":"Kim, J. et al. Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors. Nat. Genet. 48, 600\u2013606 (2016).","journal-title":"Nat. Genet."},{"key":"1140_CR77","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214\u2013218 (2013).","journal-title":"Nature"},{"key":"1140_CR78","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/biostatistics\/kxh008","volume":"5","author":"AB Olshen","year":"2004","unstructured":"Olshen, A. B., Venkatraman, E. S., Lucito, R. & Wigler, M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5, 557\u2013572 (2004).","journal-title":"Biostatistics"},{"key":"1140_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"1140_CR80","doi-asserted-by":"publisher","DOI":"10.1126\/science.abg2538","author":"LM Morton","year":"2021","unstructured":"Morton, L. M. et al. Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident. Science https:\/\/doi.org\/10.1126\/science.abg2538 (2021).","journal-title":"Science"},{"key":"1140_CR81","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/bioinformatics\/btv710","volume":"32","author":"X Chen","year":"2016","unstructured":"Chen, X. et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics 32, 1220\u20131222 (2016).","journal-title":"Bioinformatics"},{"key":"1140_CR82","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1101\/gr.221028.117","volume":"28","author":"JA Wala","year":"2018","unstructured":"Wala, J. A. et al. SvABA: genome-wide detection of structural variants and indels by local assembly. Genome Res. 28, 581\u2013591 (2018).","journal-title":"Genome Res."},{"key":"1140_CR83","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/ng.936","volume":"43","author":"AJ Bass","year":"2011","unstructured":"Bass, A. J. et al. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat. Genet. 43, 964\u2013968 (2011).","journal-title":"Nat. Genet."},{"key":"1140_CR84","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1101\/gr.141382.112","volume":"23","author":"Y Drier","year":"2013","unstructured":"Drier, Y. et al. Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. Genome Res. 23, 228\u2013235 (2013).","journal-title":"Genome Res."},{"key":"1140_CR85","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nmeth.3364","volume":"12","author":"DA Bolotin","year":"2015","unstructured":"Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380\u2013381 (2015).","journal-title":"Nat. Methods"},{"key":"1140_CR86","doi-asserted-by":"publisher","first-page":"W503","DOI":"10.1093\/nar\/gkn316","volume":"36","author":"X Brochet","year":"2008","unstructured":"Brochet, X., Lefranc, M.-P. & Giudicelli, V. IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36, W503\u2013W508 (2008).","journal-title":"Nucleic Acids Res."},{"key":"1140_CR87","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"1140_CR88","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1093\/bioinformatics\/btab135","volume":"37","author":"A Graubert","year":"2021","unstructured":"Graubert, A., Aguet, F., Ravi, A., Ardlie, K. G. & Getz, G. RNA-SeQC 2: efficient RNA-seq quality control and quantification for large cohorts. Bioinformatics 37, 3048\u20133050 (2021).","journal-title":"Bioinformatics"},{"key":"1140_CR89","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson, A. G. et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 171, 540\u2013556 (2017).","journal-title":"Cell"},{"key":"1140_CR90","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc."},{"key":"1140_CR91","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/ng2073","volume":"39","author":"B Pandit","year":"2007","unstructured":"Pandit, B. et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat. Genet. 39, 1007\u20131012 (2007).","journal-title":"Nat. Genet."},{"key":"1140_CR92","first-page":"609","volume":"12","author":"C Rommel","year":"1996","unstructured":"Rommel, C. et al. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1. Oncogene 12, 609\u2013619 (1996).","journal-title":"Oncogene"},{"key":"1140_CR93","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/emboj\/21.1.64","volume":"21","author":"AS Dhillon","year":"2002","unstructured":"Dhillon, A. S., Meikle, S., Yazici, Z., Eulitz, M. & Kolch, W. Regulation of Raf-1 activation and signalling by dephosphorylation. EMBO J. 21, 64\u201371 (2002).","journal-title":"EMBO J."},{"key":"1140_CR94","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.1093\/emboj\/cdf578","volume":"21","author":"P Provost","year":"2002","unstructured":"Provost, P. et al. Ribonuclease activity and RNA binding of recombinant human Dicer. EMBO J. 21, 5864\u20135874 (2002).","journal-title":"EMBO J."},{"key":"1140_CR95","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1073\/pnas.1311750111","volume":"111","author":"C Loenarz","year":"2014","unstructured":"Loenarz, C. et al. Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy. Proc. Natl Acad. Sci. USA 111, 4019\u20134024 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1140_CR96","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.bbrc.2005.12.019","volume":"340","author":"W Qiu","year":"2006","unstructured":"Qiu, W., Zhou, B., Darwish, D., Shao, J. & Yen, Y. Characterization of enzymatic properties of human ribonucleotide reductase holoenzyme reconstituted in vitro from hRRM1, hRRM2, and p53R2 subunits. Biochem. Biophys. Res. Commun. 340, 428\u2013434 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1140_CR97","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nmeth.1906","volume":"9","author":"J Ernst","year":"2012","unstructured":"Ernst, J. & Kellis, M. ChromHMM: automating chromatin-state discovery and characterization. Nat. Methods 9, 215\u2013216 (2012).","journal-title":"Nat. Methods"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-022-01140-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-022-01140-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-022-01140-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T19:13:44Z","timestamp":1727723624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-022-01140-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":97,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1140"],"URL":"https:\/\/doi.org\/10.1038\/s41588-022-01140-w","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]},"assertion":[{"value":"30 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following conflicts related to the CLLmap project: C.J.W. receives research support from Pharmacyclics. E.C. has been a consultant for Illumina. G.G. receives research funds from IBM and Pharmacyclics; and is an inventor on patent applications related to SignatureAnalyzer-GPU. S.S. reports honoraria for consultancy, advisory board membership, speaker honoraria, research grants and travel support from AbbVie, Amgen, AstraZeneca, Celgene, Gilead, GSK, Hoffmann La-Roche, Janssen, Novartis. C.J.W., G.G., B.A.K., Z.L. and C.K.H. are inventors on a patent \u201cCompositions, panels, and methods for characterizing chronic lymphocytic leukemia\u201d (PCT\/US21\/45144). The following conflicts are unrelated to the CLLmap project: F.N. has received honoraria from Janssen for speaking at educational activities. E.T. declares research support by AbbVie and Roche; Advisory Boards and Speakers Bureau for Janssen, AbbVie and Roche. A.W. received research funding from Pharmacyclics, Acerta, Merck, Verastem, Genmab, Nurix. J.R.B. has served as a consultant for AbbVie, Acerta\/AstraZeneca, Beigene, Bristol-Myers Squibb\/Juno\/Celgene, Catapult, Genentech\/Roche, Janssen, MEI Pharma, Morphosys AG, Novartis, Pfizer, Rigel; received research funding from Gilead, Loxo\/Lilly, Verastem\/SecuraBio, Sun, TG Therapeutics; and served on the data safety monitoring committee for Invectys. J.A.B. received research support from AstraZeneca, BeiGene, Gilead, and Pharmacyclics; travel and speaker honoraria from Janssen. X.S.P. is a cofounder of and holds an equity stake in DREAMgenics. C.J.W. holds equity in BioNTech, Inc.. E.C. has been a consultant for Takeda and NanoString Technologies; has received honoraria from Janssen and Roche for speaking at educational activities; and is an inventor on a Lymphoma and Leukemia Molecular Profiling Project patent \u201cMethod for subtyping lymphoma subtypes by means of expression profiling\u201d (PCT\/US2014\/64161). G.G. is an inventor on patent applications related to MSMuTect, MSMutSig, MSIDetect and POLYSOLVER; and is a founder and consultant of and holds privately held equity in Scorpion Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}